ClinicalTrialsFinder

Relapsed or Refractory Multiple Myeloma (RRMM) Clinical Trials in Athens, Attikí

1 recruitingAthens, Attikí, Greece

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Relapsed or Refractory Multiple Myeloma (RRMM)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company440 enrolled138 locationsNCT06615479